Skip to content

Grape Polyphenol Kinetics in Humans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01751750
Enrollment
16
Registered
2012-12-18
Start date
2011-09-30
Completion date
2011-09-30
Last updated
2017-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

The objectives of this study are the following: 1) to confirm that the administration of grape juice, resveratrol, and grape seed polyphenol extract results in a similar plasma and urinary metabolic profile in aged humans compared to rats, 2) to confirm that a combined administration of grape juice, resveratrol, and grape seed polyphenol extract result in a similar plasma and urinary metabolic profile in adults with tendencies toward metabolic syndrome compared to non-obese healthy humans, and 3) to identify the anti-inflammatory effects of the combined administration of grape juice, resveratrol, and grape seed polyphenol extract.

Interventions

OTHERGrape

16 oz. of Concord grape juice (8 oz. consumed 2 times per day; total dose of approximately 1.2 g phenolic compounds per day), 250 mg resveratrol provided as a capsule (commercially available supplement; 125 mg consumed 2 times per day), and 1 g grape seed polyphenol extract provided as a capsule (commercially available supplement; 0.5 g consumed 2 times per day).

Sponsors

Janet Novotny
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 59 Years
Healthy volunteers
Yes

Inclusion criteria

\-

Exclusion criteria

* Age \<60 years at beginning of study * Fasting glucose \> 126 mg/dl * Blood pressure \> 160/100 * Fasting total blood cholesterol \> 280 mg/dl * Fasting triglycerides \> 300 mg/dl * Presence of kidney disease, liver disease, gout, hyperthyroidism, untreated or unstable hypothyroidism, certain cancers, gastrointestinal disease, pancreatic disease, other metabolic diseases, or malabsorption syndromes * Presence of type 2 diabetes requiring the use of oral antidiabetic agents or insulin * History of bariatric or certain other surgeries related to weight control * Smokers or other tobacco users (during 6 months prior to the start of the study) * Consumption of more than 3 servings of tea, wine, or grape juice per day * Use of supplements containing grape extracts or products * Use of antibiotics during the intervention or for 3 weeks prior to the intervention period * History of eating disorders, dietary patterns, or supplement use which will interfere with the goal of the intervention * Volunteers who have lost 10% of body weight within the last 4 months * Volunteers who are unable or unwilling to give informed consent or communicate with study staff * Volunteers who self-report of alcohol or substance abuse within the past 12 months and/or current acute treatment or rehabilitation program for these problems (long-term participation in Alcoholics Anonymous is not an exclusion) * Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol

Design outcomes

Primary

MeasureTime frameDescription
Plasma polyphenols6 hoursBlood will be analyzed for polyphenols and polyphenol metabolites.
Urinary polyphenols6 hoursUrine will be analyzed for polyphenols and polyphenol metabolites.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026